Do secondary Adrenal Insufficiency (AI) patients have hypokalemia or hyperkalemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Secondary adrenal insufficiency (SAI) is often associated with low potassium levels (hypokalemia), but can also present with normal or high potassium levels due to various factors such as the underlying cause, disease severity, and presence of other electrolyte imbalances. When considering the electrolyte imbalance in SAI, it's crucial to understand that the condition's presentation can vary. According to the consensus statement on the diagnosis, treatment, and follow-up of patients with primary adrenal insufficiency 1, hyponatremia is a common finding, present in 90% of newly presenting cases, but the combination of hyponatremia and hyperkalemia is not reliable for diagnosis because serum sodium levels are often only marginally reduced, and serum potassium levels are increased in approximately one-half of the patients at the time of diagnosis. Key points to consider in the management of SAI include:

  • The diagnosis of SAI requires assessing adrenal cortex function and establishing the etiology.
  • Hyponatremia in SAI is caused by the loss of sodium in urine and increases in both plasma vasopressin and angiotensin II, which impair free water clearance.
  • Hyperkalemia, when present, is caused by aldosterone deficiency, impaired glomerular filtration, and acidosis, as noted in the study 1.
  • In some cases, particularly with severe vomiting, hypokalemia and alkalosis may be present, highlighting the variability in electrolyte imbalances in SAI.
  • Management should focus on correcting the underlying hormonal deficiencies and addressing any electrolyte imbalances, with careful monitoring of potassium levels to guide treatment.

From the Research

Secondary AI and Potassium Levels

  • The relationship between secondary adrenal insufficiency (AI) and potassium levels is not directly addressed in the provided studies.
  • However, study 2 mentions that hyperkalemia is a classic clinical sign of adrenal insufficiency.
  • Study 3 discusses potassium disorders, including hypokalemia and hyperkalemia, but does not specifically mention secondary AI.
  • Studies 4, 5, and 6 focus on adrenal insufficiency, but do not provide information on potassium levels in the context of secondary AI.

Potassium Disorders

  • Hypokalemia and hyperkalemia are common electrolyte disorders caused by changes in potassium intake, altered excretion, or transcellular shifts, as discussed in study 3.
  • The treatment of hypokalemia and hyperkalemia is also discussed in study 3, but it does not provide information on the specific relationship between secondary AI and potassium levels.

Adrenal Insufficiency

  • Secondary adrenal insufficiency is a condition caused by impaired secretion of adrenal glucocorticoid and mineralocorticoid hormones, as discussed in studies 5, 2, and 6.
  • The clinical presentation of adrenal insufficiency can be vague and undefined, requiring a high index of suspicion, as mentioned in study 2.
  • Study 6 highlights the importance of prompt diagnosis and treatment of secondary adrenal insufficiency to prevent adrenal crisis.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Adrenal insufficiency.

Pediatrics in review, 2015

Research

Potassium Disorders: Hypokalemia and Hyperkalemia.

American family physician, 2015

Research

Adrenal insufficiency presenting as hypercalcemia and acute kidney injury.

International medical case reports journal, 2016

Research

Secondary Adrenal Insufficiency: Recent Updates and New Directions for Diagnosis and Management.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.